Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10970087 | Vaccine | 2010 | 12 Pages |
Abstract
The chemokine, lymphotactin (LTN), was tested as a molecular adjuvant using bicistronic DNA vaccines encoding the protective Yersinia capsular (F1) antigen and virulence antigen (V-Ag) as a F1-V fusion protein. The LTN-encoding F1-V or V-Ag vaccines were given by the intranasal (i.n.) or intramuscular (i.m.) routes, and although serum IgG and mucosal IgA antibodies (Abs) were induced, F1-Ag boosts were required for robust anti-F1-Ag Abs. Optimal efficacy against pneumonic plague was obtained in mice i.m.-, not i.n.-immunized with these DNA vaccines. These vaccines stimulated elevated Ag-specific Ab-forming cells and mixed Th cell responses, with Th17 cells markedly enhanced by i.m. immunization. These results show that LTN can be used as a molecular adjuvant to enhance protective immunity against plague.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Hitoki Yamanaka, Teri Hoyt, Xinghong Yang, Richard Bowen, Sarah Golden, Kathryn Crist, Todd Becker, Massimo Maddaloni, David W. Pascual,